Search

everythinglearnresearchcommunity

for

Search:↓

Higher SHBG levels are linked to less severe hair loss in women, but vitamin D levels don't seem to affect hair loss.

Choosing the right starting dose of Clomiphene Citrate for ovulation induction in PCOS women is challenging; higher BMI and hormone levels may indicate resistance to the standard dose.

PCOS is a complex condition that affects women's hormonal balance and metabolism, requiring lifestyle changes and medical management.

A rare, non-cancerous ovarian tumor was successfully treated with surgery, improving the patient's symptoms.

Acupressure improves quality of life in PCOS patients.

A 16-year-old girl with HAIR-AN syndrome was treated with lifestyle changes and medications to manage her condition.

Healthy lifestyle changes, especially weight loss, can improve symptoms and overall health in people with Polycystic Ovary Syndrome, especially if they are overweight or obese.

Spearmint tea may help reduce androgen levels, but longer use is needed for noticeable effects on hirsutism.

An 86-year-old man with prostate cancer was diagnosed with a rare, low-grade breast cancer and underwent surgery but declined additional hormone therapy.

Norethisterone (jenapharm) therapy is effective for endometrial cancer.

Insulin resistance is linked to high male hormone levels in women, often seen in those with PCOS.

Antiandrogen drugs can reduce PSA levels in women with excess hair, suggesting PSA is a sign of male hormone activity in women.

Finasteride may cause breast enlargement, low testosterone a risk factor.

Neem and Zanjabeel are as effective as standard drugs for treating hirsutism in PCOD patients.

Progesterone treatment improved seizures in a woman with menstrual cycle-related epilepsy, but a wrong medication worsened her condition.

Nanocarrier systems could improve hair loss treatments by delivering drugs more effectively.

Minoxidil and finasteride are key treatments for hair loss.

5α-reductase inhibitors help treat disorders caused by DHT and have potential for future therapies.

Nanocarriers could improve minoxidil delivery for better hair loss treatment.

Transgender men need personalized cancer care and continued testosterone therapy for well-being.

PNU 157706 is a more effective treatment than finasteride for conditions caused by DHT, like enlarged prostate and hair loss.

A stronger dual 5α-reductase inhibitor could improve treatment for benign prostatic hyperplasia by further reducing DHT levels.

The method effectively measures drug impact on DHT levels in prostate treatments.

Androgenetic alopecia is a common hair loss condition caused by testosterone effects on hair follicles, leading to thinner, shorter, and less pigmented hair, diagnosed using scalp dermoscopy and treated with topical minoxidil, antiandrogen agents, and 5-alpha reductase inhibitors.

A man developed male breast cancer after four years of finasteride treatment for an enlarged prostate.

Delayed puberty affects some teens, and early treatment with hormones can help improve their growth and social well-being.

Erectile dysfunction is linked to hormone imbalances and vascular health, requiring personalized treatment approaches.

A woman's excessive hair growth was linked to a rare case of high testosterone caused by a prolactin-producing pituitary tumor.

Connarus semidecandrus Jack extract promotes hair growth and thickness, reduces prostate cancer cell growth, and could potentially be used as a treatment for hair loss.

The best long-lasting results in treating hair loss may be achieved through combination therapy, including treatments like finasteride, minoxidil, and platelet-rich plasma injections.